Synthesis of 8-Substituted Pyrazolo[1,5-a]-1,3,5-triazine Derivatives by Palladium-Catalyzed Cross-Coupling Reactions

Florence Popowycz; Philippe Bernard; Pierre Raboisson; Benoît Joseph

doi:10.1055/s-2006-958963

PAPER

Synthesis of 8-Substituted Pyrazolo[1,5-a]-1,3,5-triazine Derivatives by Palladium-Catalyzed Cross-Coupling Reactions

Florence Popowycz^a, Philippe Bernard^b, Pierre Raboisson^b, Benoît Joseph*^a
^a Laboratoire de Chimie Organique 1, UMR-CNRS 5181, Université Claude Bernard - Lyon 1, CPE - Bâtiment 308, 43 Boulevard du 11 Novembre 1918, 69622 Villeurbanne cedex, France
Fax: +33(4)72431214; e-Mail: benoit.joseph@univ-lyon1.fr;
^b Greenpharma SA, 3 Allée du Titane, 45100 Orléans, France

Abstract

All articles of this category

Abstract

8-Substituted pyrazolo[1,5-a]-1,3,5-triazine derivatives 6 were prepared from the corresponding 8-iodopyrazolo[1,5-a]-1,3,5-triazines 5 through palladium-catalyzed cross-coupling reactions. Several bioisosteres of hypoxanthine drugs 2 were then prepared by final nucleophilic aromatic substitution.

Key words

purine - bioisosteres - pyrazolo[1,5-a]-1,3,5-triazine - palladium

Full Text

References

1 Senga K. O’Brien DE. Scholten MB. Novinson T. Miller JP. Robins RK. J. Med. Chem. 1982, 25: 243

2a Gilligan PJ. Folmer BK. Hartz RA. Koch S. Nanda KK. Andreuski S. Fitzgerald L. Miller K. Marshall WJ. Bioorg. Med. Chem. 2003, 11: 4093

2b He L. Gilligan PJ. Zaczek R. Fitzgerald LW. McElroy J. Shen H.-SL. Saye JA. Kalin NH. Shelton S. Christ D. Trainor G. Hartig P. J. Med. Chem. 2000, 43: 449

3 Almansa C. de Arriba AF. Cavalcanti FL. Gómez LA. Miralles A. Merlos M. García-Rafanell J. Forn J. J. Med. Chem. 2001, 44: 350

4a Prevost G, Lonchampt M.-O, Kim S, Morgan B, Ulibarri G, and Thurieau C. inventors; PCT Int. Appl. WO 2002050079. Chem. Abstr. 2002, 137, 47234

4b Guzi TJ, and Paruch K. inventors; US Patent US 2005187219. Chem. Abstr. 2005, 143, 248417

5 Lübbers T. Angehrn P. Gmünder H. Herzig S. Kulhanek J. Bioorg. Med. Chem. Lett. 2000, 10: 821

6 Subramanyam C. Ault B. Sawutz D. Bacon ER. Singh B. Pennock PO. Kelly MD. Kraynak M. Krafte D. Treasurywala A. J. Med. Chem. 1995, 38: 587

7 Glasky AJ. Glasky MS. Ritzmann RF. Rathbone MP. Exp. Opin. Invest. Drugs 1997, 6: 1413

8 Rathbone MP. Middlemiss PJ. Crocker CE. Glasky MS. Juurlink BHJ. Ramirez JJ. Cicarelli R. Di Ioro P. Caciagli F. Exp. Opin. Invest. Drugs 1999, 8: 1255

9 Grundman M. Caparelli E. Kim HT. Morris JC. Farlow M. Rubin EH. Heidebrink J. Hake A. Ho G. Schultz AN. Schafer K. Houston W. Thomas R. Thal LJ. Life Sci. 2003, 73: 539

10 Holmes M. Maysinger D. Foerster D. Pertens E. Barlas C. Diamond J. Mol. Cell. Neurosci. 2003, 24: 568

11 Glasky AJ. inventors; PCT Int. Appl. WO 9957119. Chem. Abstr. 1999, 131, 322486

12a Zhang H.-C. Brakta M. Daves GD. Tetrahedron Lett. 1993, 34: 1571

12b Zhang H.-C. Daves GD. Organometallics 1993, 12: 1499

12c Zhang H.-C. Brakta M. Daves GD. Nucleosides Nucleotides 1995, 14: 105

13 Raboisson P. Baurand A. Cazenave J.-P. Gachet C. Schultz D. Spiess B. Bourguignon J.-J. J. Org. Chem. 2002, 67: 8063

14a Kobe J. Robins RK. O’Brien DE. J. Heterocycl. Chem. 1974, 199

14b Tam SY.-K. Klein RS. Wempen I. Fox JJ. J. Org. Chem. 1979, 44: 4547

14c Vogel A. Troxler F. Helv. Chim. Acta 1975, 58: 761

15a Raboisson P. Schultz D. Lugnier C. Bourguignon J.-J. Tetrahedron Lett. 2002, 43: 9501

15b Raboisson P. Schultz D. Lugnier C. Mathieu R. Bourguignon J.-J. Tetrahedron Lett. 2003, 44: 703

16 Liu Y. Li K. Macromol. Rapid Commun. 2002, 23: 739

17 Bernard P, Raboisson P, and Joseph B. inventors; PCT Int. Appl. WO 2004011464. Chem. Abstr. 2004, 140, 146171